Inactive Instrument

Analyst Reco. Metacrine, Inc.

Equities

Jefferies Analyst Starts Metacrine at Hold, Adjusts Price Target to $1 From $2	21-12-29	MT
METACRINE : Canaccord Genuity Downgrades Metacrine to Hold Rating From Buy, Adjusts Price Target to $1 From $19	21-10-22	MT
METACRINE : Jefferies Downgrades Metacrine to Hold from Buy, Adjusts Price Target to $2 from $14	21-10-22	MT
METACRINE : HC Wainwright Downgrades Metacrine to Neutral from Buy	21-10-22	MT
METACRINE : RBC Downgrades Metacrine to Sector Perform From Outperform, Price Target to $2.50 From $22, Amid 'Mixed' NASH Data; Speculative Risk Kept	21-10-22	MT
METACRINE : HC Wainwright Starts Metacrine at Buy With $15 Price Target	21-06-14	MT
METACRINE : RBC Reduces Price Target on Metacrine to $22 From $25, Maintains Outperform Rating, Speculative Risk Qualifier	21-05-14	MT

No results for this search